Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.48

+0.1%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (584)	6/30/2000 9:14:35 AM
From: scaram(o)uche	Read Replies (1) of 1475

Touching further on the reaction to the PPL news..... It's been obvious, for some time, that "cloning" procedures might push aside the need for the inbred herd. With respect to hyperacute rejection...... we've dealt with that issue repeatedly in this thread. PPL is certainly a late-comer to the concept. Putting the two concepts together in one pig would be a huge advance. If PPL did it first, they may well have made a significant contribution to one part of the puzzle. However, the observation in no way, negatively, impacts the need for XenoMune. The ready supply of porcine organs that allow one to circumvent hyperacute rejection would do nothing other than facilitate XenoMune. So.... the stock takes a quick 15% hit on the news. That's a reflection of how misunderstood this company (and stock) is by some of its shareholders. Lets have some more misunderstanding..... I love discounts. I still maintain that both arms of the business plan are leveraged like crazy. If MEDI shows convincing activity in psoriasis, 507 is still on track, IMO, to bring in huge revenues. My opinion only, please get your own. I have an ever-increasing stake/interest in the stock's appreciation.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next